Wall Street analyst estimates for SeaStar Medical Holding Corporation (ICU): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.95 | ||
| 2026-08-12 | $-0.91 | $-0.97 | +6.2% |
| 2026-05-13 | $-0.90 | $-0.73 | -23.3% |
| 2026-03-25 | $-0.80 | $-0.97 | +17.5% |
| 2025-11-13 | $-1.30 | $-1.50 | +13.3% |
| 2025-08-13 | $-1.80 | $-4.30 | +58.1% |
| 2025-05-14 | $-4.40 | $-5.20 | +15.4% |
| 2025-03-27 | $-9.00 | $-8.90 | -1.1% |
Valuation Ratios
| Price / Book | 3.00 |
| EV / EBITDA | -0.11 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | $135000 | $1.2M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | $53000 |
| Gross Profit | 0 | 0 | 0 | 0 | $135000 | $1.2M |
| Research & Development | $4.0M | $2.8M | $2.5M | $6.0M | $9.1M | $7.5M |
| Selling, General & Admin | $2.4M | $1.7M | $6.9M | $8.0M | $8.9M | $5.8M |
| Operating Expenses | $6.5M | $4.4M | $11.6M | $14.2M | $18.0M | $13.4M |
| Operating Income | -$6.5M | -$4.4M | -$11.6M | -$14.2M | -$17.8M | -$12.2M |
| EBITDA | 0 | -$4.4M | -$11.6M | -$11.1M | -$24.6M | -$12.2M |
| Interest Expense | $3.3M | $212000 | $630000 | $1.1M | $244000 | $329000 |
| Pre-tax Income | -$3.3M | -$4.6M | -$12.2M | -$26.2M | -$24.8M | -$12.1M |
| Income Tax | $9000 | -$1000 | $1000 | 0 | $3000 | $3000 |
| Net Income | -$3.3M | -$4.6M | -$12.2M | -$26.2M | -$24.8M | -$12.2M |
| EPS | $-0.10 | $-88.10 | $-233.80 | $-302.62 | $-66.30 | $-5.86 |
| EPS (Diluted) | $-0.10 | $-88.10 | $-233.80 | $-302.62 | $-66.30 | $-5.86 |
| Shares Outstanding (Diluted) | $52164 | $52164 | $52134 | $86681 | $374400 | $20.7M |
Price
| Price | $3.08 |
| Market Cap | $9M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ADTX · AIMD · APLM · ATHA · BLRX · CTXR · LNAI
Explore sector: Healthcare · Biotechnology
More sections of ICU: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks